In 2025, the Depo-Provera lawsuit is real and legitimate. Millions have used it — but the risk of brain tumors was only ...

Shares of Pfizer Inc. PFE advanced 1.26% to $26.43 Friday, on what proved to be an all-around favorable trading session for ...

For decades, women have trusted Depo-Provera, a birth control injection manufactured by Pfizer, as a convenient and effective ...

Cases in Texas and other states are on the rise, but most of the infected were not vaccinated. Here’s what to know about the ...

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other best ...

Pfizer’s chief executive in Ireland has told the Government the system of giving patients access to new medicines has become “increasingly bureaucratic”. In a letter to Simon Harris when he was still ...

NEW YORK – After acquiring Lucira Health in a bankruptcy auction in 2023, Pfizer has decided to shut down the business, a Pfizer spokesperson told GenomeWeb.

Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...

Columnist Jennifer Lynne assesses the effects of Pfizer's decision to halt production of its hemophilia B gene therapy, Beqvez.

FDA reform needs to be underpinned by strategy, not ‘indiscriminate’ cuts The Trump administration could save the lives of ...

The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and ...

For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...